Jacobs Levy Equity Management’s Aravive, Inc. Common Stock ARAV Stock Holding History

Jacobs Levy Equity Management’s Portfolio ARAV Stock Details ARAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-12,127	Closed	-$45K	–	1102
2021 Q3	$45K	Buy	+12,127	New	+$51.8K	﹤0.01%	1018
2021 Q1	–	Sell	-36,414	Closed	-$205K	–	1139
2020 Q4	$205K	Sell	36,414 -921	-2%	-$5.05K	﹤0.01%	963
2020 Q3	$175K	Buy	37,335 +23,209	+164%	+$165K	﹤0.01%	972
2020 Q2	$164K	Buy	+14,126	New	+$168K	﹤0.01%	976
2018 Q4	–	Sell	-28,578	Closed	-$240K	–	1090
2018 Q3	$240K	Buy	+28,578	New	+$301K	﹤0.01%	902
2018 Q1	–	Sell	-10,044	Closed	-$133K	–	1081
2017 Q4	$133K	Sell	10,044 -2,883	-22%	-$37.1K	﹤0.01%	941
2017 Q3	$190K	Buy	12,927 +5,981	+86%	+$603K	﹤0.01%	873
2017 Q2	$727K	Buy	6,946 +4,446	+178%	+$478K	0.02%	620
2017 Q1	$320K	Sell	2,500 -300	-11%	-$31.6K	0.01%	717
2016 Q4	$250K	Sell	2,800 -12,867	-82%	-$975K	﹤0.01%	799
2016 Q3	$1.15M	Sell	15,667 -1,481	-9%	-$107K	0.02%	542
2016 Q2	$1.14M	Sell	17,148 -1,885	-10%	-$107K	0.02%	553
2016 Q1	$916K	Buy	+19,033	New	+$1.01M	0.02%	587

Other funds holding ARAV

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Jacobs Levy Equity Management's ARAV Position: Q4 2021 in Review

Jacobs Levy Equity Management sold out of Aravive, Inc. Common Stock (ARAV) in Q4 2021, closing a stake of 12,127 shares — an estimated $45K sold.

Jacobs Levy Equity Management first reported a position in ARAV in Q1 2016 and held it in 13 quarters. The position peaked at $1.15M in Q3 2016. 36 funds tracked by Wall St. Rank hold ARAV as of Q4 2021.

Jacobs Levy Equity Management reported no remaining Aravive, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Jacobs Levy Equity Management sold 12,127 Aravive, Inc. Common Stock shares in Q4 2021, an estimated $45K.
Jacobs Levy Equity Management first reported a position in Aravive, Inc. Common Stock in Q1 2016 and held it in 13 quarters.
Jacobs Levy Equity Management's Aravive, Inc. Common Stock position peaked at $1.15M in Q3 2016.
36 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q4 2021.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2021, filed 14 Feb 2022.